(Q34011138)

30 July 2017

1 reference

title

Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment (English)

1 reference

30 July 2017

main subject

autism spectrum disorder

0 references

0 references

1

Angela M Reiersen

1 reference

30 July 2017

Richard D Todd

2

1 reference

30 July 2017

language of work or name

1 reference

1 April 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

30 July 2017

published in

1 reference

30 July 2017

volume

8

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

657-669

1 reference

Are pervasive developmental disorders and attention-deficit/hyperactivity disorder distinct disorders?

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

The comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: results of a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

ADHD symptom subtypes in children with pervasive developmental disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Attention deficit hyperactivity disorder symptoms in pervasive developmental disorders: association with autistic behavior domains and coexisting psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Social incompetence in children with ADHD: possible moderators and mediators in social-skills training

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Toward a new psychometric definition of social disability in children with attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Impact of executive functioning and symptoms of attention deficit hyperactivity disorder on children's peer relations and school performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Patterns of friendship among girls with and without attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Autistic symptoms in children with attention deficit-hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Social impairment in Hyperkinetic Disorder - relationship to psychopathology and environmental stressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Deficits in reciprocal social behavior in male twins: evidence for a genetically independent domain of psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Reciprocal social behavior in children with and without pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Rapid quantitative assessment of autistic social impairment by classroom teachers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Attention deficit disorder and age of onset of problem behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

DCD and ADHD: a genetic study of their shared aetiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Motor coordination and kinaesthesis in boys with attention deficit-hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Timing and force control in boys with attention deficit hyperactivity disorder: subtype differences and the effect of comorbid developmental coordination disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Motor persistence and inhibition in autism and ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Overflow movements predict impaired response inhibition in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Neuromotor functioning in children with Tourette syndrome with and without attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Gender study of neuropsychological and neuromotor function in children with Tourette syndrome with and without attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Dyspraxia in autism: association with motor, social, and communicative deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Motor signs distinguish children with high functioning autism and Asperger's syndrome from controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Deficits in attention, motor control, and perception: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

ADHD and DCD: a relationship in need of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Subtle executive impairment in children with autism and children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Executive functions and developmental psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

The relationship between measures of executive function, motor performance and externalising behaviour in 5- and 6-year-old children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Working memory, processing speed, and set-shifting in children with developmental coordination disorder and attention-deficit-hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

The relationship between motor coordination, executive functioning and attention in school aged children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Atypical brain development: a conceptual framework for understanding developmental learning disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Comorbidity, co-occurrence, continuum: What's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Toward localizing genes underlying cerebral asymmetry and mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Dopamine and the regulation of cognition and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Is attention-deficit/hyperactivity disorder an energy deficiency syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Prenatal Smoking Exposure and Dopaminergic Genotypes Interact to Cause a Severe ADHD Subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Gene-environment interactions in the development of combined type ADHD: evidence for a synapse-based model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Annotation: velo-cardio-facial syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Psychopathology in 22q11 deletion syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Treating the core features of autism: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Autism spectrum disorders: emerging pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Intervention for autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

An update on pharmacologic treatments for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

The status of pharmacotherapy for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Clonidine treatment of hyperactive and impulsive children with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

A prospective open trial of guanfacine in children with pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Attention-deficit/hyperactivity disorder pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Pharmacogenetics of antipsychotics: useful for the clinician?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Adolescent outcome of boys with attention-deficit/hyperactivity disorder and social disability: results from a 4-year longitudinal follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

Attention-Deficit/Hyperactivity Disordered and Control Boys' Responses to Social Success and Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.657

21 January 2018

Identifiers

DOI

10.1586/14737175.8.4.657

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sqqz5icftrerjj24kl45bddzti

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_sqqz5icftrerjj24kl45bddzti

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sqqz5icftrerjj24kl45bddzti

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/sqqz5icftrerjj24kl45bddzti

1 reference